by Hanna | Jan 3, 2024 | Blog Post
Thousands of life sciences companies from across the U.S. compete every day to bring the next generation of treatments and cures to market. Within this ecosystem, pharmaceutical manufacturers play a key role in developing new therapies and cures. By mobilizing their...
by Hanna | Dec 13, 2023 | Blog Post, PULSE Partner
Ohio has had incredible success in the life sciences in recent years. The first-ever novel gene therapy brain infusion for Parkinson’s disease was developed here, along with the first-ever gene therapy treatment for Duchenne’s muscular dystrophy. Add state-of-the-art...
by Hanna | Dec 12, 2023 | Blog Post
To view the full event recording, click here. Across the life sciences industry, companies engage in a constant “relay race” to bring new and groundbreaking treatments to market. The critical partnerships and “hand-offs” between companies of all sizes are core...
by Hanna | Nov 28, 2023 | Blog Post
For nearly four decades, policymakers have prioritized bipartisan policies that incentivize investment in groundbreaking medical research – aiming to make new innovations accessible for millions of Americans. As a result, the legislative foundation fueling life...
by Hanna | Nov 13, 2023 | Blog Post
Over the past several decades, the U.S. life sciences ecosystem has emerged as a global leader in innovation with more than 2,300 biopharmaceutical companies spanning every state. Pro-innovation mergers and acquisitions (M&A) have been a critical component of the...
by Hanna | Nov 7, 2023 | Blog Post
Every day, life sciences innovators discover promising new therapies with the potential to transform our approach to treating life-altering or life-threatening diseases. But what lies between these initial discoveries and an FDA-approved treatment reaching patients is...
